跳至主要内容
临床试验/NCT05209568
NCT05209568Enrolling By Invitation不适用

Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten

Boston Children's Hospital6 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2023年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
400
试验地点
6
主要终点
Change in serum interleukin-2 (IL-2) level from baseline to 4 hours after a single oral dose of gluten

研究概览

简要总结

This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.

详细描述

This is a multi-site open-label single dose gluten challenge study. Participants will provide a blood sample for measurement of cytokines before and 4 hours after eating gluten powder.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
2 Years 至 101 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • On a gluten-free diet for ≥ 4 weeks
  • Willing to consume gluten for research
  • For the celiac disease arm, diagnosis confirmed by serology and/or histology

排除标准

  • Wheat allergy
  • Type 1 diabetes
  • BMI z-score < -2
  • History of more than minimal symptoms following gluten exposure on a gluten-free diet
  • Comorbid condition that in the opinion of the investigator would interfere with study participation or would confound study results

研究组 & 干预措施

Healthy Controls

Experimental

Individuals without a diagnosis of celiac disease

干预措施: Gluten Powder (Dietary Supplement)

Celiac Disease

Experimental

Individuals with a confirmed diagnosis of celiac disease based on serology and/or histology

干预措施: Gluten Powder (Dietary Supplement)

结局指标

主要结局

Change in serum interleukin-2 (IL-2) level from baseline to 4 hours after a single oral dose of gluten

时间窗: Baseline, 4 hours

To determine the change in serum IL-2 level from baseline after a single oral dose of gluten

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nan Du

Assistant Professor of Pediatrics

Boston Children's Hospital

研究点 (6)

Loading locations...

相似试验